InterAx Biotech AG, a spin-off of the Paul Scherrer Institute PSI and ETH Zurich, based at PARK INNOVAARE, is building a proprietary systems biology platform...
More details More detailsInterAx Biotech AG participated in a “business boosting” week in Boston, USA, in June, 2016. As part of venturelab’s international program, 10 high...
More detailsWith their biosensors, pharmaceutical industry can save 100 million CHF in the development of new drugs. No wonder the newly born spin-off of the Paul...
More detailsOn 24 November 2016, Switzerland’s leading conference on innovation and technology, the Swiss Innovation Forum, will take place for the eleventh time...
More details“PLAY” was the motto of the Swiss Innovation Forum on Thursday, 24 November. PARK INNOVAARE, together with four other sites of Switzerland Innovation,...
More detailsStarting with two technology companies in September 2015, PARK INNOVAARE has shown quite a positive development so far. Today, PARK INNOVAARE counts a...
More detailsEach year, startup.ch launches the TOP 100 STARTUP AWARD. From over 100,000 young companies, the 100 most innovative and promising Swiss start-ups are...
More detailsScientific advisory boards set the bar for the quality of research and development performed in big pharma, medium biotech and small start-ups. Their excellence...
More detailsCollaborations speed up innovation. InterAx Biotech AG, a spin-off of the Paul Scherrer Institute (PSI) and ETH Zurich, based at PARK INNOVAARE, and Professor...
More detailsThis summer you voted for PARK INNOVAARE’s residents to help them win the TOP 100 START-UP AWARD. Now we are pleased to congratulate InterAx Biotech...
More detailsFor four consecutive years, Venturelab has been selecting leading Swiss start-up to represent the country on the Chinese market. Ten best companies form...
More detailsEach year, startup.ch launches the TOP 100 STARTUP AWARD. From over 100,000 young companies, the 100 most innovative and promising Swiss start-ups are...
More details